Details of the Drug Reposition

General Information of This Drug (ID: DMFJ1OW)

Drug Name
ADXS-NEO   DMFJ1OW
Drug Type
Vaccine

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Colon cancer DISVC52G 2B90.Z Phase 1 [1]
Colorectal cancer DISNH7P9 2B91.Z Phase 1 [2]
Non-small-cell lung cancer DIS5Y6R9 2C25.Y Phase 1 [1]
Head and neck cancer DISBPSQZ 2D42 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT03265080) Expressing Personalized Tumor Antigens Study (NEO). U.S. National Institutes of Health.